Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changyanning Granules in Endoscopic Resection of Colorectal Polyps
NCT06927258Enrolling by invitation
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2024
- Primary completion
- Sep 2025
- Modality
- TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Randomised, double-blind trial of Changyanning in Colorectal polyps (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Serum Interleukin-6 at 2 weeks, Incidence of Complications at 2 weeks and 3 more. Started Nov 2024; status: enrolling by invitation.
02
Drugs
Changyanning
03
Conditions
Colorectal polyps
Beyond the preview
Go deeper on NCT06927258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06927258.